/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | BBLGBone Biologics Corp |
|---|---|
| Last close | $0.33close 2026-11-09 |
| Change % | -0.63%close 2026-11-09 |
| Market cap | $1Mclose 2026-11-09 |
| P/E | loss, no P/E |
| Revenue | $1.1B⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenues As ofFY ending 2020-12-31 Filing10-K · 0001493152-21-008887 · filed 2021-04-15 Open the filing on EDGAR →Open the XBRL payload → |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | 0.0%FY to 2020-12-31, older period |
| Net income | $-3108991⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 FilingDEF 14A · 0001493152-26-040640 · filed 2026-08-28 Open the filing on EDGAR →Open the XBRL payload →CiteBone Biologics Corp (BBLG), us-gaap:NetIncomeLoss: -3,108,991 USD, fiscal year ended 2025-12-31. Form DEF 14A, accession 0001493152-26-040640, filed 2026-08-28. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001419554/us-gaap/NetIncomeLoss.json |
| Net margin | periods differ |
| EPS (diluted) | $-2.65⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-12-31 Filing10-K · 0001493152-26-008564 · filed 2026-03-02 Open the filing on EDGAR →Open the XBRL payload →CiteBone Biologics Corp (BBLG), us-gaap:EarningsPerShareDiluted: -2.65 USD per share, fiscal year ended 2025-12-31. Form 10-K, accession 0001493152-26-008564, filed 2026-03-02. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001419554/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 3FY to 2020-12-31, older period |
| Altman Z-ScoreUNVALIDATED | inputs not filed |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | — |